Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Y Yap

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|February 1, 1980
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancerH Y Yap, G R Blumenschein, M J Keating, et al.
American Journal of Clinical Oncology|October 1, 1982
Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancerH Y Yap, G R Blumenschein, G N Hortobagyi, et al.
Cancer Research|March 1, 1983
Bisantrene, an active new drug in the treatment of metastatic breast cancerH Y Yap, B S Yap, G R Blumenschein, et al.
Cancer Treatment Reports|March 1, 1987
Percutaneous hepatic arterial infusion of cisplatin for metastatic breast cancerG Fraschini, G Fleishman, H Y Yap, et al.
Lancet (London, England)|April 25, 2003
Severe acute respiratory syndrome (SARS): infection controlThomas Sing Tao Li, Thomas A Buckley, Florence H Y Yap, et al.
JAMA|April 8, 1983
Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancerA W Mughal, G N Hortobagyi, H A Fritsche, et al.
Journal of Intensive Care|September 11, 2021
Effect of the COVID-19 pandemic on cardiac arrest resuscitation practices and outcomes in non-COVID-19 patientsSau Ki Tong, Lowell Ling, Jack Zhenhe Zhang, et al.
Cancer|July 1, 1979
Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancerH Y Yap, G R Blumenschein, C K Tashima, et al.
Critical Care Medicine|February 6, 2004
Limitation of life support: frequency and practice in a Hong Kong intensive care unitThomas A Buckley, Gavin M Joynt, Peggy Y H Tan, et al.
Cancer|March 1, 1983
Multimodal treatment of locoregionally advanced breast cancerG N Hortobagyi, G R Blumenschein, W Spanos, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|February 1, 1980
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancerH Y Yap, G R Blumenschein, M J Keating, et al.
American Journal of Clinical Oncology|October 1, 1982
Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancerH Y Yap, G R Blumenschein, G N Hortobagyi, et al.
Cancer Research|March 1, 1983
Bisantrene, an active new drug in the treatment of metastatic breast cancerH Y Yap, B S Yap, G R Blumenschein, et al.
Cancer Treatment Reports|March 1, 1987
Percutaneous hepatic arterial infusion of cisplatin for metastatic breast cancerG Fraschini, G Fleishman, H Y Yap, et al.
Lancet (London, England)|April 25, 2003
Severe acute respiratory syndrome (SARS): infection controlThomas Sing Tao Li, Thomas A Buckley, Florence H Y Yap, et al.
JAMA|April 8, 1983
Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancerA W Mughal, G N Hortobagyi, H A Fritsche, et al.
Journal of Intensive Care|September 11, 2021
Effect of the COVID-19 pandemic on cardiac arrest resuscitation practices and outcomes in non-COVID-19 patientsSau Ki Tong, Lowell Ling, Jack Zhenhe Zhang, et al.
Cancer|July 1, 1979
Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancerH Y Yap, G R Blumenschein, C K Tashima, et al.
Critical Care Medicine|February 6, 2004
Limitation of life support: frequency and practice in a Hong Kong intensive care unitThomas A Buckley, Gavin M Joynt, Peggy Y H Tan, et al.
Cancer|March 1, 1983
Multimodal treatment of locoregionally advanced breast cancerG N Hortobagyi, G R Blumenschein, W Spanos, et al.
Pageof 11